Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.

MLA

Tree, Julia A., et al. “Unfractionated Heparin Inhibits Live Wild Type SARS-CoV-2 Cell Infectivity at Therapeutically Relevant Concentrations.” British Journal of Pharmacology, vol. 178, no. 3, Feb. 2021, pp. 626–35. EBSCOhost, https://doi.org/10.1111/bph.15304.

APA

Tree, J. A., Turnbull, J. E., Buttigieg, K. R., Elmore, M. J., Coombes, N., Hogwood, J., Mycroft, W. C. J., Lima, M. A., Skidmore, M. A., Karlsson, R., Chen, Y., Yang, Z., Spalluto, C. M., Staples, K. J., Yates, E. A., Gray, E., Singh, D., Wilkinson, T., Page, C. P., & Carroll, M. W. (2021). Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. British Journal of Pharmacology, 178(3), 626–635. https://doi.org/10.1111/bph.15304

Chicago

Tree, Julia A., Jeremy E. Turnbull, Karen R. Buttigieg, Michael J. Elmore, Naomi Coombes, John Hogwood, West, Courtney J. Mycroft, et al. 2021. “Unfractionated Heparin Inhibits Live Wild Type SARS-CoV-2 Cell Infectivity at Therapeutically Relevant Concentrations.” British Journal of Pharmacology 178 (3): 626–35. doi:10.1111/bph.15304.